Publications by authors named "J Matthew Rhett"

Claim this Profile
I
Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.
Imran Khan, Akiko Koide, Mariyam Zuberi, Gayatri Ketavarapu, Eric Denbaum, J Matthew Rhett

Cell Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The connexin 43 carboxyl terminal mimetic peptide αCT1 prompts differentiation of a collagen scar matrix in humans resembling unwounded skin.
Jade Montgomery, William J Richardson, Spencer Marsh, J Matthew Rhett, Francis Bustos

FASEB J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biology, pathology, and therapeutic targeting of RAS.
J Matthew Rhett, Imran Khan, John P O'Bryan

Adv Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of RAS: New hope for drugging the "undruggable".
Imran Khan, J Matthew Rhett, John P O'Bryan

Biochim Biophys Acta Mol Cell Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HUNK Phosphorylates Rubicon to Support Autophagy.
Joelle N Zambrano, Scott T Eblen, Melissa Abt, J Matthew Rhett, Robin Muise-Helmericks

Int J Mol Sci· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis